Resources
For the latest in biomarkers & precision medicine, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Liquid Biopsies
Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions
Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.
Personalised Medicine
Life Science Players Join €23m European Project for Precision Medicine, PRECISEU
The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.
Biomarker Discovery & Development
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Liquid Biopsies
Feinstein Institutes Links Blood Biomarkers to Psychosis in Alzheimer's Patients
The global aging population means that rates of Alzheimer's disease are expected to reach 14 million patients by 2060, many of whom will experience psychosis.
Genomic Biomarkers
ZERO Precision Medicine Programme Reports Outstanding Efficacy in High-Risk Paediatric Cancers
The first-of-its-kind trial presents a positive outlook for cancer types with historically poor survival rates.
Genomic Biomarkers
Hope for New Prognostic Biomarkers & Therapeutic Options From Tumour Metabolism-Targeting Breast Cancer Study
Understanding the interplay between the tumour microenvironment and immunometabolic states could unlock a wealth of therapeutic targets and biomarkers.
Diagnostic Development
New Zika-Specific Synthetic Biomarker Can Differentiate From Dengue Virus
A test that identifies Zika distinct from dengue could make a definite impact to expectant mothers and reproductive-age women that are at risk from the mosquito-borne disease.
Diagnostic Development
Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA
A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
New MND Early Diagnostic Test: a 'Game-Changer' for Research on the Disease
Detecting the aggregation of TDP-43 spells a new diagnostic tool for MND.
Biomarker Discovery & Development
The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research
Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Digital Biomarkers
Speech-Analysis Tool for the Early Detection of Alzheimer's Handed to Linus Health in Acquisition
Aural Analysis's Speech Vitals and Linus Health's expansion into linguistic analysis herald a promising era in early detection and treatment.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biomarkers